BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/30/2025 6:43:34 AM | Browse: 10 | Download: 0
| Category |
Pathology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Differences of immunohistochemical profiling of MOC-31, caveolin-1, connexin-43, Ki-67 in ameloblastic fibroma, ameloblastic fibrodentinoma, ameloblastic fibro-odontoma, and odontomas
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Natalia González Umpiérrez, Estefania Sicco, Felipe Silveira, Aurita Veronica Beovide and Ronell Bologna-Molina |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ronell Bologna-Molina, PhD, Professor, Department of Diagnostics in Oral Pathology and Oral Medicine, Faculty of Dentistry, University of the Republic, Las Heras 1925, Montevideo 11600, Uruguay. ronellbologna@hotmail.com |
| Key Words |
Caveolin-1; MOC-31; Connexin-43; Ki-67; Odontogenic tumors |
| Core Tip |
This study compared the immunohistochemical expression of caveolin-1, MOC-31, connexin-43 (Cx-43), and Ki-67 in ameloblastic fibroma (AF), ameloblastic fibrodentinoma (AFD), ameloblastic fibro-odontoma (AFO), and odontoma (O). AF, AFD, and AFO showed similar epithelial and mesenchymal profiles, with lower expression in O. Significant differences in MOC-31 and Cx-43 between AF/AFO and O suggest that AFD and AFO may represent variants of AF rather than developing odontomas. These findings contribute to understanding the biological behavior and classification of mixed odontogenic tumors. |
| Citation |
Umpiérrez NG, Sicco E, Silveira F, Beovide AV, Bologna-Molina R. Differences of immunohistochemical profiling of MOC-31, caveolin-1, connexin-43, Ki-67 in ameloblastic fibroma, ameloblastic fibrodentinoma, ameloblastic fibro-odontoma, and odontomas. World J Exp Med 2025; In press |
 |
Received |
|
2025-10-20 02:07 |
 |
Peer-Review Started |
|
2025-10-20 02:07 |
 |
First Decision by Editorial Office Director |
|
2025-10-23 08:35 |
 |
Return for Revision |
|
2025-10-23 08:35 |
 |
Revised |
|
2025-11-03 22:47 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2025-12-30 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-12-30 06:43 |
 |
Articles in Press |
|
2025-12-30 06:43 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
2220-315x (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345